Literature DB >> 21760536

A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient.

Casper Jansen1, Piero Parchi, Sabina Capellari, Rosaria Strammiello, Elise G P Dopper, John C van Swieten, Wouter Kamphorst, Annemieke J M Rozemuller.   

Abstract

A rare case of Gerstmann-Sträussler-Scheinker disease in a 36-year-old Dutch man is reported. The clinical phenotype was characterized by slowly progressive cognitive decline, later followed by ataxia and parkinsonism. Neuropathologic findings consisted of numerous amyloid plaques in the cerebellum, which showed positive staining for the abnormal prion protein (PrP(Sc)). In addition, there were tau accumulations around numerous amyloid deposits in the cerebral cortex, striatum, hippocampal formation, and midbrain. There was no spongiform degeneration. Western blot analysis showed the co-occurrence of 2 distinct abnormal prion protein species comprising an unglycosylated, protease-resistant fragment of approximately 8 kd, which was found to be truncated at both N- and C-terminal ends by epitope mapping, and a detergent-insoluble but protease-sensitive form of full-length PrP(Sc). Sequence analysis disclosed a mutation at codon 131 of the prion protein gene (PRNP), resulting in a valine-for-glycine substitution (G131V). The patient was heterozygous at the polymorphic codon 129 and carried the mutation on the methionine allele. To our knowledge, this is the second family worldwide in which this mutation has been identified. Gerstmann-Sträussler-Scheinker disease should be considered in patients with a clinical diagnosis of familial frontotemporal dementia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21760536     DOI: 10.1097/NEN.0b013e3182270c54

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.

Authors:  Daniela Saverioni; Silvio Notari; Sabina Capellari; Ilaria Poggiolini; Armin Giese; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

Review 2.  Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.

Authors:  Pawel Tacik; Monica Sanchez-Contreras; Rosa Rademakers; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Neurodegener Dis       Date:  2015-11-10       Impact factor: 2.977

3.  Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Carla A Ibrahim-Verbaas; Maaike Schuur; Rosaria Strammiello; Patrizia Corrado; Matthew T Bishop; Willem A van Gool; Marcel M Verbeek; Frank Baas; Wesley van Saane; Wim G M Spliet; Gerard H Jansen; Cornelia M van Duijn; Annemieke J M Rozemuller
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 4.  Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.

Authors:  Ilaria Poggiolini; Daniela Saverioni; Piero Parchi
Journal:  Int J Cell Biol       Date:  2013-12-24

5.  Activation of the unfolded protein response and granulovacuolar degeneration are not common features of human prion pathology.

Authors:  Vera I Wiersma; Wim van Hecke; Wiep Scheper; Martijn A J van Osch; Will J M Hermsen; Annemieke J M Rozemuller; Jeroen J M Hoozemans
Journal:  Acta Neuropathol Commun       Date:  2016-10-28       Impact factor: 7.801

6.  Structural effects of the highly protective V127 polymorphism on human prion protein.

Authors:  Laszlo L P Hosszu; Rebecca Conners; Daljit Sangar; Mark Batchelor; Elizabeth B Sawyer; Stuart Fisher; Matthew J Cliff; Andrea M Hounslow; Katherine McAuley; R Leo Brady; Graham S Jackson; Jan Bieschke; Jonathan P Waltho; John Collinge
Journal:  Commun Biol       Date:  2020-07-29

Review 7.  Genetics of prion diseases.

Authors:  Sarah E Lloyd; Simon Mead; John Collinge
Journal:  Curr Opin Genet Dev       Date:  2013-03-19       Impact factor: 5.578

8.  Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.

Authors:  Brent Race; Katie Williams; Andrew G Hughson; Casper Jansen; Piero Parchi; Annemieke J M Rozemuller; Bruce Chesebro
Journal:  Acta Neuropathol Commun       Date:  2018-02-20       Impact factor: 7.801

Review 9.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

10.  Impaired transmissibility of atypical prions from genetic CJDG114V.

Authors:  Ignazio Cali; Fadi Mikhail; Kefeng Qin; Crystal Gregory; Ani Solanki; Manuel Camacho Martinez; Lili Zhao; Brian Appleby; Pierluigi Gambetti; Eric Norstrom; James A Mastrianni
Journal:  Neurol Genet       Date:  2018-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.